600572 康恩贝
已收盘 09-02 15:00:00
资讯
新帖
简况
康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%
证券之星 · 08-31 22:20
康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%
每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%
证券之星 · 08-30
每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%
股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%
证券之星 · 08-27
股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%
康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%
证券之星 · 08-25
康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%
康恩贝上半年净利润同比增长6.83%
投资观察 · 08-25
康恩贝上半年净利润同比增长6.83%
每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权
证券之星 · 08-23
每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权
股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》
证券之星 · 08-19
股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》
森林包装(605500)披露购买东阳市康恩贝印刷包装有限公司100%股权进展公告,8月17日股价上涨1.59%
证券之星 · 08-17
森林包装(605500)披露购买东阳市康恩贝印刷包装有限公司100%股权进展公告,8月17日股价上涨1.59%
异动快报:康恩贝(600572)8月12日14点33分触及涨停板
证券之星 · 08-12
异动快报:康恩贝(600572)8月12日14点33分触及涨停板
康恩贝:截至7月31日,公司股东总户数为86,827户
证券之星 · 08-10
康恩贝:截至7月31日,公司股东总户数为86,827户
每周股票复盘:森林包装(605500)拟购康恩贝印刷包装100%股权
证券之星 · 08-09
每周股票复盘:森林包装(605500)拟购康恩贝印刷包装100%股权
每周股票复盘:康恩贝(600572)2026年8月11日至26日限制行权
证券之星 · 08-09
每周股票复盘:康恩贝(600572)2026年8月11日至26日限制行权
森林包装(605500.SH)以5098.27万元竞得康恩贝印刷包装100%股权
智通财经 · 08-07
森林包装(605500.SH)以5098.27万元竞得康恩贝印刷包装100%股权
股市必读:康恩贝新发布《关于2022年股票期权激励计划限制行权期间的提示性公告》
证券之星 · 08-06
股市必读:康恩贝新发布《关于2022年股票期权激励计划限制行权期间的提示性公告》
康恩贝(600572)披露2022年股票期权激励计划限制行权期间安排,8月4日股价下跌0.23%
证券之星 · 08-04
康恩贝(600572)披露2022年股票期权激励计划限制行权期间安排,8月4日股价下跌0.23%
股市必读:康恩贝(600572)7月31日董秘有最新回复
证券之星 · 08-03
股市必读:康恩贝(600572)7月31日董秘有最新回复
康恩贝:截至2026年6月30日,公司股东总户数为90,755户
证券之星 · 07-31
康恩贝:截至2026年6月30日,公司股东总户数为90,755户
康恩贝(600572.SH)子公司麝香通心滴丸新适应症临床试验申请获批
智通财经 · 07-24
康恩贝(600572.SH)子公司麝香通心滴丸新适应症临床试验申请获批
康恩贝:与浙江中医药大学等高校开展产学研合作
证券之星 · 07-20
康恩贝:与浙江中医药大学等高校开展产学研合作
康恩贝:现阶段公司暂无将肠炎宁作为药品在美国上市的规划
证券之星 · 07-20
康恩贝:现阶段公司暂无将肠炎宁作为药品在美国上市的规划
加载更多
公司概况
公司名称:
浙江康恩贝制药股份有限公司
所属行业:
医药制造业
上市日期:
2004-04-12
主营业务:
浙江康恩贝制药股份有限公司的主营业务是药品、中药材饮片及健康消费品的研发、制造与销售业务。公司的主要产品是“前列康”普乐安片及胶囊、“天保宁”银杏叶制剂、“康恩贝”肠炎宁、“金奥康”奥美拉唑产品、“金笛”复方鱼腥草合剂、“金艾康”汉防己甲素、“金康速力”乙酰半胱氨酸泡腾片、“至心砃”麝香通心滴丸、“康恩贝”“宝芝林”“养营堂”品牌系列保健食品和功能性食品。公司工业树种选育与产业关键技术项目获国家科学技术进步二等奖、数智中药大健康产业体系及应用项目获浙江省科学技术进步二等奖。
发行价格:
8.25
{"stockData":{"symbol":"600572","market":"SH","secType":"STK","nameCN":"康恩贝","latestPrice":4.43,"timestamp":1788332401000,"preClose":4.52,"halted":0,"volume":47303100,"delay":0,"changeRate":-0.0199,"floatShares":2532000000,"shares":2539000000,"eps":0.1964,"marketStatus":"已收盘","change":-0.09,"latestTime":"09-02 15:00:00","open":4.48,"high":4.53,"low":4.42,"amount":211000000,"amplitude":0.0243,"askPrice":4.44,"askSize":3240,"bidPrice":4.43,"bidSize":1513,"shortable":0,"etf":0,"ttmEps":0.1964,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.52,"symbolType":"stock","openAndCloseTimeList":[[1788312600000,1788319800000],[1788325200000,1788332400000]],"highLimit":4.97,"lowLimit":4.07,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2538532031,"isCdr":false,"pbRate":1.59,"roa":"--","peRate":22.556008,"roe":"5.26%","epsLYR":0.19,"committee":-0.052454,"marketValue":11246000000,"turnoverRate":0.0187,"status":1,"floatMarketCap":11216000000},"requestUrl":"/m/hq/s/600572","defaultTab":"news","newsList":[{"id":"2663079009","title":"康恩贝(600572)披露公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告,8月31日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079009","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079009?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:20","pubTimestamp":1788186043,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,康恩贝报收于4.44元,较前一交易日下跌1.33%,最新总市值为112.71亿元。近日,浙江康恩贝制药股份有限公司发布《关于公开挂牌转让东阳康恩贝100%股权事项完成工商变更登记备案的公告》。公告显示,公司根据第十一届董事会第十七次(临时)会议决议,通过浙江产权交易所公开挂牌转让所持东阳市康恩贝印刷包装有限公司100%股权。双方于2026年8月17日签署股权交易合同,康恩贝已于8月19日收到全部股权转让款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0060","600572","BK0012","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663704323","title":"每周股票复盘:康恩贝(600572)Q2扣非净利增61.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663704323","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663704323?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:19","pubTimestamp":1788049153,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,康恩贝报收于4.5元,较上周的4.32元上涨4.17%。本周,康恩贝8月26日盘中最高价报4.65元。本周关注点来自业绩披露要点:2026年第二季度扣非净利润2.16亿元,同比上升61.12%。股本股东变化截至2026年7月31日,公司股东户数为8.68万户,较7月20日减少2112户,减幅2.37%。第二季度单季主营收入17.96亿元,同比增7.3%;单季归母净利润1.79亿元,同比增9.2%;单季扣非净利润2.16亿元,同比增61.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600572","BK0097","BK0028","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662032744","title":"股市必读:康恩贝中报 - 第二季度单季净利润同比增长9.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662032744","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662032744?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:28","pubTimestamp":1787776091,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘,康恩贝报收于4.44元,上涨3.26%,换手率4.91%,成交量124.27万手,成交额5.59亿元。业绩披露要点:2026年中报显示扣非净利润4.25亿元,同比大增43.38%;第二季度扣非净利润同比增长61.12%。业绩披露要点财务报告2026年中报显示:主营收入37.01亿元,同比上升10.21%;归母净利润3.78亿元,同比上升6.83%;扣非净利润4.25亿元,同比上升43.38%;第二季度单季度扣非净利润2.16亿元,同比上升61.12%;负债率29.37%,毛利率56.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700009793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662614753","title":"康恩贝(600572)披露2026年半年度报告全文,8月25日股价上涨2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662614753","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662614753?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:36","pubTimestamp":1787668564,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,康恩贝报收于4.3元,较前一交易日上涨2.14%,最新总市值为109.16亿元。该股当日开盘4.19元,最高4.32元,最低4.18元,成交额达2.6亿元,换手率为2.4%。近日,浙江康恩贝制药股份有限公司披露《2026年半年度报告全文》。公司无半年度利润分配预案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","BK0060","BK0028","BK0012","600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193039397","title":"康恩贝上半年净利润同比增长6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193039397","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193039397?lang=zh_cn&edition=full","pubTime":"2026-08-25 21:29","pubTimestamp":1787664565,"startTime":"0","endTime":"0","summary":"8月25日消息——浙江康恩贝制药股份有限公司(证券代码:600572)披露了2026年半年度业绩报告,期内净利润较上年同期实现了6.83%的增长。\n这一数据反映出公司在上半年经营中的稳健表现。尽管市场环境复杂多变,康恩贝仍保持了业绩的持续增长势头。具体财务细节已在公司的官方报告中予以公布。\n据悉,该业绩数据来源于路透社投资者简报,信息更新于2026年8月25日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0097","BK0012","BK0060","BK0188","BK0239","600572"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279214","title":"每周股票复盘:森林包装(605500)5098.27万元竞得康恩贝印包100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279214","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661279214?lang=zh_cn&edition=full","pubTime":"2026-08-23 04:56","pubTimestamp":1787432169,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,森林包装报收于6.95元,较上周的6.9元上涨0.72%。本周,森林包装8月18日盘中最高价报7.15元。8月21日盘中最低价报6.79元。本周关注点公司公告汇总:森林包装以5,098.27万元竞得东阳市康恩贝印刷包装有限公司100%股权。2026年8月17日,公司与浙江康恩贝制药股份有限公司签署《东阳市康恩贝印刷包装有限公司100%股权交易合同》。股权变更登记将在交易凭证出具后10个工作日内办理完毕,资产及资料移交在股权交易完成后10日内完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","605500","BK0012","BK0028","BK0060","600572","BK0222","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491321","title":"股市必读:森林包装新发布《森林包装集团股份有限公司关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491321?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:21","pubTimestamp":1787077272,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘,森林包装报收于7.12元,上涨1.57%,换手率0.95%,成交量3.93万手,成交额2777.34万元。当日关注点交易信息汇总:8月18日主力资金净流入399.92万元,占总成交额14.4%。公司公告汇总:森林包装于8月17日与浙江康恩贝制药签署股权交易合同,以5,098.27万元收购东阳市康恩贝印刷包装有限公司100%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0222","BK0239","600572","BK0188","BK0060","605500","BK0028","BK0012","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489903","title":"森林包装(605500)披露购买东阳市康恩贝印刷包装有限公司100%股权进展公告,8月17日股价上涨1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660489903?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:54","pubTimestamp":1786960488,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘,森林包装报收于7.01元,较前一交易日上涨1.59%,最新总市值为29.05亿元。近日,森林包装集团股份有限公司发布《关于购买东阳市康恩贝印刷包装有限公司100%股权的进展公告》。公告显示,2026年8月6日,公司以5,098.27万元在浙江产权交易所以公开竞拍方式中标取得东阳市康恩贝印刷包装有限公司100%股权;2026年8月17日,公司与浙江康恩贝制药股份有限公司签订《东阳市康恩贝印刷包装有限公司100%股权交易合同》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700024146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0222","BK0239","BK0028","BK0012","600572","BK0060","BK0097","BK0188","605500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921128","title":"异动快报:康恩贝(600572)8月12日14点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658921128?lang=zh_cn&edition=full","pubTime":"2026-08-12 14:35","pubTimestamp":1786516524,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息,14点33分康恩贝(600572)触及涨停板。其所属行业中药目前上涨。领涨股为康恩贝。该股为保健品,食品,互联网医疗概念热股,当日保健品概念上涨1.3%,食品概念上涨1.09%,互联网医疗概念上涨0.89%。8月11日的资金流向数据方面,主力资金净流出1226.54万元,占总成交额6.37%,游资资金净流出464.76万元,占总成交额2.41%,散户资金净流入1691.29万元,占总成交额8.78%。近5日资金流向一览见下表:康恩贝主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200020240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600572","BK0097","BK0060","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981316","title":"康恩贝:截至7月31日,公司股东总户数为86,827户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658981316?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:48","pubTimestamp":1786351697,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月31日A股股东人数是多少?谢谢康恩贝回复:尊敬的投资者您好!截至7月31日,公司股东总户数为86,827户。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600572","BK0097","BK0028","BK0060","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658367512","title":"每周股票复盘:森林包装(605500)拟购康恩贝印刷包装100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2658367512","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658367512?lang=zh_cn&edition=full","pubTime":"2026-08-09 03:03","pubTimestamp":1786215794,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,森林包装报收于6.85元,较上周的6.57元上涨4.26%。本周关注点来自公司公告汇总:森林包装拟以5,098.27万元收购东阳市康恩贝印刷包装有限公司100%股权。联合纸业少数股东的实际控制人按持股比例为不超过50,000.00万元担保提供反担保。森林包装集团股份有限公司于2026年8月6日通过浙江产权交易所公开竞拍方式,以5,098.27万元中标浙江康恩贝制药股份有限公司持有的东阳市康恩贝印刷包装有限公司100%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900001005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0028","BK0188","BK0060","BK0222","605500","600572","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658732116","title":"每周股票复盘:康恩贝(600572)2026年8月11日至26日限制行权","url":"https://stock-news.laohu8.com/highlight/detail?id=2658732116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658732116?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:56","pubTimestamp":1786211776,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,康恩贝报收于4.34元,较上周的4.34元上涨0.0%。本周,康恩贝8月4日盘中最高价报4.43元。本周关注点公司公告汇总:康恩贝2026年8月11日至26日实施股票期权限制行权。公司公告汇总浙江康恩贝制药股份有限公司根据相关规定,对2022年股票期权激励计划处于自主行权期间的股票期权实施限制行权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0012","BK0239","BK0028","600572","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661354","title":"森林包装(605500.SH)以5098.27万元竞得康恩贝印刷包装100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661354","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657661354?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:55","pubTimestamp":1786089333,"startTime":"0","endTime":"0","summary":"智通财经APP讯,森林包装(605500.SH)发布公告,公司以转让价5098.27万元,在浙江产权交易所公开竞拍的方式中标,浙江康恩贝制药股份有限公司(简称“康恩贝”)持有东阳市康恩贝印刷包装有限公司(简称“康恩贝印刷包装”)100%股权。公司的现有包装板块主要为客户提供工业品、消费品的包装服务和解决包装方案,康恩贝印刷多年来主营医药类包装盒的制造销售。从产业上与公司具有较强的互补性。本次股权交易有助于公司自工业品、消费品包装向医药类包装的产业链布局,有利于公司产业的提升,增强抗风险能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"森林包装(605500.SH)以5098.27万元竞得康恩贝印刷包装100%股权","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK0028","BK0012","BK0188","BK0222","BK0239","BK0060","600572","605500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521857","title":"股市必读:康恩贝新发布《关于2022年股票期权激励计划限制行权期间的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657521857?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:14","pubTimestamp":1785950052,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,康恩贝报收于4.28元,下跌2.06%,换手率2.37%,成交量59.97万手,成交额2.56亿元。当日关注点交易信息汇总:8月5日主力资金净流入1005.06万元,占总成交额3.92%。公司公告汇总:康恩贝将于2026年8月11日至8月26日对2022年股票期权激励计划实施限制行权,涉及首次授予第二个行权期及预留授予第一个行权期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0012","600572","BK0028","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656540205","title":"康恩贝(600572)披露2022年股票期权激励计划限制行权期间安排,8月4日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656540205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656540205?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:18","pubTimestamp":1785853104,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,康恩贝报收于4.37元,较前一交易日下跌0.23%,最新总市值为110.93亿元。该股当日开盘4.39元,最高4.43元,最低4.35元,成交额达1.71亿元,换手率为1.54%。公告显示,公司对2022年股票期权激励计划处于自主行权期间的股票期权实施限制行权,限制行权期为2026年8月11日至2026年8月26日,涉及首次授予股票期权第二个行权期和预留授予股票期权第一个行权期,期权代码分别为1000000271和1000000535,可行权期均为2025年11月28日至2026年11月27日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600572","BK0028","BK0060","BK0188","BK0097","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656432013","title":"股市必读:康恩贝(600572)7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656432013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656432013?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:35","pubTimestamp":1785699311,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,康恩贝报收于4.34元,上涨0.46%,换手率1.62%,成交量41.1万手,成交额1.78亿元。董秘最新回复投资者: 请问截止2026年6月30日和7月20日公司股东人数是多少?截至2026年6月30日,公司股东总户数为90,755户;截至2026年7月20日,公司股东总户数为88,939户。交易信息汇总资金流向7月31日主力资金净流出18.74万元,占总成交额0.11%;游资资金净流出619.42万元,占总成交额3.48%;散户资金净流入638.17万元,占总成交额3.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","600572","BK0188","BK0012","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655574443","title":"康恩贝:截至2026年6月30日,公司股东总户数为90,755户","url":"https://stock-news.laohu8.com/highlight/detail?id=2655574443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655574443?lang=zh_cn&edition=full","pubTime":"2026-07-31 18:21","pubTimestamp":1785493279,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)07月31日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年6月30日和7月20日公司股东人数是多少?谢谢康恩贝回复:尊敬的投资者您好!截至2026年6月30日,公司股东总户数为90,755户;截至2026年7月20日,公司股东总户数为88,939户。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100032384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0188","600572","BK0012","BK0097","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653707595","title":"康恩贝(600572.SH)子公司麝香通心滴丸新适应症临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2653707595","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653707595?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:18","pubTimestamp":1784881106,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康恩贝(600572.SH)发布公告,近日,公司全资子公司内蒙古康恩贝药业有限公司(简称“内蒙古康恩贝”)收到国家药品监督管理局核准签发的有关麝香通心滴丸新适应症的《药物临床试验批准通知书》。此次申请的新适应症为射血分数保留的心力衰竭(中医辨证气虚血瘀证),给药途径为口服。据悉,至心砃®麝香通心滴丸为内蒙古康恩贝自主研发、生产的中成药,于2008年获批上市,功能主治:芳香益气通脉,活血化瘀止痛,用于冠心病稳定型劳累性心绞痛,中医辨证气虚血瘀证,症见胸痛胸闷,心悸气短,神倦乏力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","600572","BK0060","IBBQ","BK0239","BK0188","BK0028","BK0097","IBBJ","PSYK","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652295500","title":"康恩贝:与浙江中医药大学等高校开展产学研合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2652295500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652295500?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:00","pubTimestamp":1784534444,"startTime":"0","endTime":"0","summary":"公司与省内浙江大学、浙江中医药大学、浙江农林大学等高校开展了产学研合作,公司旗下子公司浙江中医药大学中药饮片公司依托浙江中医药大学科研资源,重点激活“宝芝林”品牌,打造具有康恩贝特色的“药食同源”大健康产品,老年保健品也是其未来探索方向之一。控股股东浙药集团今年1月实施完成增持康恩贝约2%股份,现阶段暂无资产注入计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000023214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0097","600572","BK0012","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652502295","title":"康恩贝:现阶段公司暂无将肠炎宁作为药品在美国上市的规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2652502295","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652502295?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:00","pubTimestamp":1784534442,"startTime":"0","endTime":"0","summary":"证券之星消息,康恩贝(600572)07月20日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,董秘,美国多洲出现由寄生虫引发的肠道疾病,患者被感染后上吐下泻,请问我们的肠炎宁是否可以治疗此疾病,毕竟作为消化道中药龙头。贵司有无借此契机进军美国市场,拯救世界就靠康恩贝了!康恩贝回复:尊敬的投资者您好!针对寄生虫感染引发的肠道疾病,治疗方案需遵从专业医师诊断指导。现阶段公司暂无将肠炎宁作为药品在美国上市的规划。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000023210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600572","BK0060","BK0188","BK0012","BK0097","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788369565933,"stockEarnings":[{"period":"1week","weight":-0.0023},{"period":"1month","weight":0.0114},{"period":"3month","weight":0.1069},{"period":"6month","weight":0.0538},{"period":"1year","weight":0.0186},{"period":"ytd","weight":0.0302}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0346},{"period":"3month","weight":-0.0287},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.0216},{"period":"ytd","weight":-0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江康恩贝制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"86827人(较上一季度减少2.37%)","perCapita":"29159股","listingDate":"2004-04-12","address":"浙江省金华市兰溪市康恩贝大道1号","registeredCapital":"253853万元","survey":" 浙江康恩贝制药股份有限公司的主营业务是药品、中药材饮片及健康消费品的研发、制造与销售业务。公司的主要产品是“前列康”普乐安片及胶囊、“天保宁”银杏叶制剂、“康恩贝”肠炎宁、“金奥康”奥美拉唑产品、“金笛”复方鱼腥草合剂、“金艾康”汉防己甲素、“金康速力”乙酰半胱氨酸泡腾片、“至心砃”麝香通心滴丸、“康恩贝”“宝芝林”“养营堂”品牌系列保健食品和功能性食品。公司工业树种选育与产业关键技术项目获国家科学技术进步二等奖、数智中药大健康产业体系及应用项目获浙江省科学技术进步二等奖。","listedPrice":8.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康恩贝,600572,康恩贝股票,康恩贝股票老虎,康恩贝股票老虎国际,康恩贝行情,康恩贝股票行情,康恩贝股价,康恩贝股市,康恩贝股票价格,康恩贝股票交易,康恩贝股票购买,康恩贝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}